HU900916D0 - Treatment of sicknesses caused by the lack of iodine - Google Patents

Treatment of sicknesses caused by the lack of iodine

Info

Publication number
HU900916D0
HU900916D0 HU90916A HU91690A HU900916D0 HU 900916 D0 HU900916 D0 HU 900916D0 HU 90916 A HU90916 A HU 90916A HU 91690 A HU91690 A HU 91690A HU 900916 D0 HU900916 D0 HU 900916D0
Authority
HU
Hungary
Prior art keywords
iodine
treatment
composition
lack
breast cancer
Prior art date
Application number
HU90916A
Other languages
Hungarian (hu)
Other versions
HUT57050A (en
Inventor
William R Ghent
Bernard A Eskin
Original Assignee
William R Ghent
Bernard A Eskin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by William R Ghent, Bernard A Eskin filed Critical William R Ghent
Publication of HU900916D0 publication Critical patent/HU900916D0/en
Publication of HUT57050A publication Critical patent/HUT57050A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

This invention relates to a composition for use in the treatment of iodine deficiency diseases such as fibrocystic dysplasia breast cancer, endometriosis and premenstrual syndrome. The composition may also be used for the prophylaxis of breast cancer. More particularly, this invention relates to a composition for the treatment of iodine deficiency diseases, the composition comprising a solution of elemental iodine (I2) which may also be referred to as metallic iodine or iodine metal. The elemental iodine is soluble in water which leaves it thermodynamically free. The term "aqueous iodine" may also be used to refer to such an aqueous solution.
HU90916A 1989-01-03 1990-01-03 Process for treating diseases with lake of iodine HUT57050A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/292,968 US5171582A (en) 1985-07-31 1989-01-03 Treatment of iodine deficiency diseases

Publications (2)

Publication Number Publication Date
HU900916D0 true HU900916D0 (en) 1991-10-28
HUT57050A HUT57050A (en) 1991-11-28

Family

ID=23127029

Family Applications (1)

Application Number Title Priority Date Filing Date
HU90916A HUT57050A (en) 1989-01-03 1990-01-03 Process for treating diseases with lake of iodine

Country Status (13)

Country Link
US (1) US5171582A (en)
EP (1) EP0377266B1 (en)
JP (1) JP2994741B2 (en)
AT (1) ATE106738T1 (en)
AU (1) AU639222B2 (en)
BR (1) BR9006990A (en)
CA (1) CA1336889C (en)
DE (1) DE68915987T2 (en)
DK (1) DK128291A (en)
ES (1) ES2057098T3 (en)
HU (1) HUT57050A (en)
MC (1) MC2172A1 (en)
WO (1) WO1990007339A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5589198A (en) * 1985-07-31 1996-12-31 943038 Ontario, Inc. Treatment of iodine deficiency diseases
US5250304A (en) * 1985-07-31 1993-10-05 Ghent William R Treatment of iodine deficiency diseases
US6019970A (en) * 1985-07-31 2000-02-01 Ghent William R. Treatment of iodine deficiency diseases
US5910318A (en) * 1991-03-28 1999-06-08 943038 Ontario Inc. Treatment of iodine deficiency diseases
US5955101A (en) * 1991-03-28 1999-09-21 943038 Ontario Inc. Dry starch-iodine pharmaceutical formulations
ES2114934T3 (en) * 1991-03-28 1998-06-16 Ontario Inc 943038 DRY PHARMACEUTICAL FORMULATIONS BASED ON STARCH / IODINE.
US5554600A (en) * 1995-01-20 1996-09-10 Eli Lilly And Company Methods for inhibiting endometriosis
EP0722727A1 (en) * 1995-01-20 1996-07-24 Eli Lilly And Company Benzofuran derivatives for inhibiting uterine fibroid disease
US5489587A (en) * 1995-01-20 1996-02-06 Eli Lilly And Company Benzofurans used to inhibit bone loss
US6238644B1 (en) 1997-09-03 2001-05-29 Wayne State University Method for treating and/or imaging breast cancer using radioactive iodide
US5885592A (en) * 1997-10-29 1999-03-23 Symbollon Corporation Methods and pharmaceutical compositions for oral delivery of molecular iodine
AU2005274638A1 (en) * 2004-08-20 2006-02-23 Dennis Hardy O'dowd Method of detecting and treating allogenic cells responsible for endometriosis
US9511151B2 (en) 2010-11-12 2016-12-06 Uti Limited Partnership Compositions and methods for the prevention and treatment of cancer
US10988516B2 (en) 2012-03-26 2021-04-27 Uti Limited Partnership Methods and compositions for treating inflammation
US9603948B2 (en) 2012-10-11 2017-03-28 Uti Limited Partnership Methods and compositions for treating multiple sclerosis and related disorders
MX2016005822A (en) 2013-11-04 2016-12-02 Uti Limited Partnership Methods and compositions for sustained immunotherapy.
CA2984485A1 (en) 2015-05-06 2016-12-15 Uti Limited Partnership Nanoparticle compositions for sustained therapy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4384960A (en) * 1979-11-13 1983-05-24 Polley R D Iodine dispenser and method of dispensing iodine
US4816255A (en) * 1985-07-31 1989-03-28 Ghent William R Treatment of iodine deficiency breast syndrome
FR2611733B1 (en) * 1987-02-26 1989-06-16 Rhone Poulenc Chimie IODINE-CONTAINING DIORGANOPOLYSILOXANE GUM COMPOSITION FOR WATER TREATMENT

Also Published As

Publication number Publication date
DK128291A (en) 1991-08-21
US5171582A (en) 1992-12-15
BR9006990A (en) 1991-11-12
AU639222B2 (en) 1993-07-22
DE68915987D1 (en) 1994-07-14
HUT57050A (en) 1991-11-28
DK128291D0 (en) 1991-07-01
MC2172A1 (en) 1992-05-22
EP0377266B1 (en) 1994-06-08
JP2994741B2 (en) 1999-12-27
ES2057098T3 (en) 1994-10-16
EP0377266A1 (en) 1990-07-11
CA1336889C (en) 1995-09-05
JPH04503949A (en) 1992-07-16
ATE106738T1 (en) 1994-06-15
WO1990007339A1 (en) 1990-07-12
AU4819990A (en) 1990-08-01
DE68915987T2 (en) 1995-01-12

Similar Documents

Publication Publication Date Title
HU900916D0 (en) Treatment of sicknesses caused by the lack of iodine
NZ224231A (en) Gels containing metal chlorite as disinfectant
HK1014239A1 (en) Sublingual dosage forms containing apomorphine for use in the treatment of erectile dysfunction
GR3005528T3 (en)
PH25527A (en) N-glycosylated carboxamide derivatives
DE3267352D1 (en) Novel aroylimidazolones
IT8547596A0 (en) CHELATING COMPOUNDS FOR THE REDUCTION OF METAL IONS CONTAINED IN BODY TISSUES, PARTICULARLY IRON, PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH COMPOUNDS AND PREPARATION PROCEDURE
SE8005580L (en) HARVEXT COMPOSITION AND PROCEDURE FOR ITS MANUFACTURING
FR2442250A1 (en) GLASS COMPOSITIONS AND CEMENTS IN WHICH THESE COMPOSITIONS ARE INCORPORATED
ES8304919A1 (en) Dichloroamino acid derivatives useful as potent germicidal and fungicidal agents.
HK1003833A1 (en) Alkaloids from mappia foetida the use thereof and formulations containing them
RO79426B1 (en) Medicinal composition for treating neuroviroses
NO912528L (en) TREATMENT OF DISEASES CONNECTED WITH IOD Deficiency.
IL70649A0 (en) Triazine derivative,its preparation and its use as herbicide
DE69012687T2 (en) Metal protective compositions, their manufacturing process and metal protection process.
JPS53142315A (en) Manufacture of cu-ni-sn alloy material
WO2003030884A3 (en) Use of solasonine for the treatment of skin tumors
OTA Corrosion of Iron in Concentrated Alkaline Solution
PT74513B (en) Process for the preparation of metal complexes of ethylene-1,2-bis-dithiocarbamic acid and 8-hydroxychinolin and of fungicidal and bactericidal compositions containing them
IT1240747B (en) Pharmaceutical compound that reduces the oxygen radicals and its preparation
MD421C2 (en) Aminoacids derivatives and the acid additive salts thereof
PT99146A (en) Process for the preparation of inclusion complexes with silibinine and pharmaceutical compositions containing them
ES8702484A1 (en) Sequestering agent for chelating calcium and/or magnesium ions
GR850484B (en)

Legal Events

Date Code Title Description
DFC9 Refusal of application